Thomas, L
This usually includes dietary changes that can be maintained long term, regular physical activity, attention to sleep, stress management, and treatment of underlying medical conditions
Independently verify all licensing, compounding, sourcing, and marketing requirements applicable to your facility and jurisdiction before acting.
The appropriate level of care depends on symptom severity, but serious or rapidly worsening symptoms should not be managed by simply waiting for them to pass
Clinical scenarios warranting consideration of GLP-1 therapy include: Type 2 diabetes management : Per ADA 2024 Standards of Care, GLP-1 RAs may be considered as initial therapy in patients with established atherosclerotic cardiovascular disease (ASCVD), high ASCVD risk, chronic kidney disease (CKD), or heart failure, or as add-on therapy when glycemic targets aren't met Established cardiovascular disease : Several GLP-1 receptor agonists have demonstrated cardiovascular risk reduction in patients with type 2 diabetes and established ASCVD Chronic kidney disease : While SGLT2 inhibitors are generally prioritized for CKD with type 2 diabetes when eGFR allows, GLP-1 RAs may provide complementary benefits Obesity with complications : When lifestyle interventions produce insufficient weight loss in patients with obesity-related comorbidities Important safety considerations include: Contraindications : Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
This combination of nutritional science and artisanal culinary technique makes MealPro the premier GLP-1 weight loss meal delivery service on the market
